CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
7 hedge funds and large institutions have $8.75M invested in Celyad Oncology SA American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$501K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$40.1K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$110K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$9.06K |
| 3 |
Morgan Stanley
New York
|
-$2.64K |
| 4 |
Millennium Management
New York
|
-$35 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $8.33M | +$501K | +50,227 | +6% |
|
|
2
Morgan Stanley
New York
| $314K | -$2.64K | -267 | -0.8% |
|
|
3
Wells Fargo
San Francisco,
California
| $99K | +$40.1K | +4,047 | +68% |
|
|
4
UBS Group
Zurich,
Switzerland
| $7K | -$9.06K | -918 | -56% |
|
5
Bank of Montreal
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
6
Millennium Management
New York
| $126 | -$35 | -3,518 | -22% |
|
|
7
Renaissance Technologies
New York
| – | -$110K | -10,300 | Closed |
|